FDA Okays Bryan Cervical Disc
The US Food and Drug Administration (FDA) has approved a novel artificial cervical disc, BRYAN, for the treatment of single-level cervical disc diseases like radiculopathy and/or myelopathy. The titanium-polyurethane disc, developed by Medtronic Inc, is implanted in milled pockets of adjacent vertebral bodies from C3-C7 to substitute a diseased or bulging natural cervical disc.
-
Interventional Spine(R), Inc. Announces The Completion Of Another Successful Cervical Surgery, With Its PERPOS(R) Percutaneous Cervical System
FDA Concerned with Cancer Rates for New Spine Device
DePuy Spine launches CONCORDE Bullet Vertebral Body Replacement
DiscAssist gets CE Mark certification
Pioneer Surgical’s nanOss cervical cage implanted successfully
